Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,123.66
(
-0.21%
)
US TECH 100
26,355.40
(
0.20%
)
Dow Jones
48,841.05
(
-0.61%
)
Brent Oil
110.43
(
5.77%
)
Bitcoin
76,060.97
(
-0.37%
)
News Focus
News Focus
Post# of 257465
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jq1234

Send PM Follow Ignore
Followers 69
Posts 4516
Boards Moderated 0
Alias Born 12/13/2009

jq1234

Re: DewDiligence post# 109214

Thursday, 11/18/2010 4:16:22 PM

Thursday, November 18, 2010 4:16:22 PM

Post# of 257465
It's not semantic. Look at Denosumab study endpoint in HRPC, it is time to skeletal-related events (SREs). EXEL184 won't be tested this way, it is for cancer treatment, with OS endpoint likely. They are not comparable.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today